Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Sep 21, 2017; 23(35): 6437-6447
Published online Sep 21, 2017. doi: 10.3748/wjg.v23.i35.6437
Table 1 Baseline characteristics (n = 115 patients, 127 nodules) n (%)
CharacteristicsValues
Age
Median (range)73 (49-92)
Sex
Male/Female88 (76.5)/27 (23.5)
Etiology
Hepatitis B/C/B + C13 (11.3)/85 (73.9)/2 (1.7)
Alcohol10 (8.7)
NASH2 (1.7)
PBC3 (2.6)
Child-Pugh class
A/B99 (86.1)/16 (13.9)
Location of target nodules
Anterior segment39 (30.7)
Posterior segment37 (29.1)
Medial segment27 (21.3)
Lateral segment24 (18.9)
Size of target nodules (mm)114.00 ± 10.30 (5.0-56.7)
Chemotherapeutic drug
Cisplatin/Epirubicin87 (68.5)/40 (31.5)
Table 2 Evaluation of efficacy 6 mo after transcatheter arterial chemoembolization according to the modified response evaluation criteria in solid tumors criteria
CRPRSDPDTotal
All nodules8126137127
(63.8)(20.5)(10.2)(5.5)
Anterior segment2675139
Posterior segment2283437
Medial segment1484127
Lateral segment1931124
Patient with Child-Pugh grade A561710386
(65.1)(19.8)(11.6)(3.5)
Anterior segment1955130
Posterior segment1451121
Medial segment963018
Lateral segment1411117
Patients with Child-Pugh grade B2593441
(61.0)(22.0)(7.3)(9.7)
Anterior segment72009
Posterior segment832316
Medial segment52119
Lateral segment52007
Table 3 Hepatocellular carcinoma location coefficient in the complete response and non-complete response groups
Non-CR groupCR groupP value
All lobes0.630.8< 0.001
Right lobe0.680.81< 0.05
Medial segment0.490.8< 0.01
Lateral segment0.730.74> 0.05
Patients with Child-Pugh grade A
All lobes0.620.82< 0.001
Right lobe0.590.71< 0.01
Medial segment0.490.81< 0.05
Lateral segment0.650.67> 0.05
Patients with Child-Pugh grade B
All lobes0.730.75> 0.05
Right lobe0.840.79> 0.05
Medial segment0.430.69> 0.05
Lateral segment0.720.69> 0.05